09/09/2025 07:00
Varian Announces CE Mark for Embozene in Genicular Artery Embolisation, Expanding Treatment for Knee Osteoarthritis

Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory milestone makes Embozene the first—and only—embolic agent to be CE Marked specifically for GAE, a minimally invasive procedure intended to target inflammation and help relieve pain in patients with knee osteoarthritis. Knee osteoarthritis is widespread, with a reported prevalence of nearly 375 million c...

AFP launches online course to tackle climate misinformation

Leading global news agency AFP releases an online training course to equip journalists and journalism students with tools and techniques to tackle climate misinformation.

Leading global news agency AFP releases an online training course to equip journalists and journalism students with tools and techniques to tackle climate misinformation.
Anglais